Egypt - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingVaccine Price in Egypt - 2021
Contents:
- Vaccine Price in Egypt (CIF) - 2022
- Vaccine Price in Egypt (FOB) - 2022
- Vaccine Imports in Egypt
- Vaccine Exports in Egypt
Vaccine Price in Egypt (CIF) - 2022
The average vaccine import price stood at $599,669 per ton in 2022, shrinking by -4% against the previous year. Over the period under review, import price indicated a resilient increase from 2012 to 2022: its price increased at an average annual rate of +6.3% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, vaccine import price increased by +36.9% against 2019 indices. The most prominent rate of growth was recorded in 2016 an increase of 39% against the previous year. The import price peaked at $624,879 per ton in 2021, and then declined slightly in the following year.
There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was China ($1,182,276 per ton), while the price for India ($173,685 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (+26.0%), while the prices for the other major suppliers experienced more modest paces of growth.
Vaccine Price in Egypt (FOB) - 2022
In 2022, the average vaccine export price amounted to $202,369 per ton, with an increase of 47% against the previous year. Overall, the export price saw resilient growth. The most prominent rate of growth was recorded in 2020 an increase of 128% against the previous year. As a result, the export price reached the peak level of $521,595 per ton. From 2021 to 2022, the average export prices remained at a somewhat lower figure.
There were significant differences in the average prices for the major external markets. In 2022, amid the top suppliers, the country with the highest price was Tunisia ($908,894 per ton), while the average price for exports to Saudi Arabia ($43,372 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Tunisia (+127.7%), while the prices for the other major destinations experienced more modest paces of growth.
Vaccine Imports in Egypt
In 2022, after three years of growth, there was significant decline in purchases abroad of vaccines for human medicine, when their volume decreased by -30.8% to 474 tons. Over the period under review, imports, however, showed significant growth. The pace of growth was the most pronounced in 2021 with an increase of 173% against the previous year. As a result, imports reached the peak of 685 tons, and then contracted sharply in the following year.
In value terms, vaccine imports fell dramatically to $284M in 2022. Overall, imports, however, saw a significant expansion. The growth pace was the most rapid in 2021 with an increase of 204%. As a result, imports reached the peak of $428M, and then fell rapidly in the following year.
| Import of Vaccine in Egypt (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| China | 19.4 | 2.6 | 117 | 78.0 | 59.0% |
| United Arab Emirates | N/A | N/A | 92.4 | 61.8 | -33.1% |
| United States | 5.0 | 6.7 | 55.3 | 37.0 | 94.9% |
| Netherlands | N/A | 13.2 | 28.3 | 18.9 | 19.7% |
| France | 7.8 | 31.9 | 20.9 | 14.0 | 21.5% |
| Belgium | 13.3 | 28.5 | 17.8 | 11.9 | -3.6% |
| Denmark | 7.2 | 16.5 | 11.3 | 7.5 | 1.4% |
| India | 25.4 | 8.1 | 6.7 | 5.7 | -39.2% |
| Ireland | 3.0 | 0.6 | 2.9 | 2.0 | -12.6% |
| Indonesia | 2.9 | 4.3 | 1.4 | 1.1 | -27.6% |
| Malaysia | 0.1 | N/A | N/A | N/A | 0% |
| Others | 6.7 | 28.2 | 74.4 | 46.4 | 90.6% |
| Total | 90.8 | 141 | 428 | 284 | 46.2% |
Top Suppliers of Vaccine to Egypt in 2022:
- United Arab Emirates (154.7 tons)
- China (66.0 tons)
- United States (50.5 tons)
- France (43.9 tons)
- India (33.1 tons)
- Belgium (29.0 tons)
- Netherlands (22.7 tons)
- Denmark (16.7 tons)
- Ireland (10.4 tons)
- Indonesia (9.8 tons)
Vaccine Exports in Egypt
In 2022, approx. 1.1 tons of vaccines for human medicine were exported from Egypt; reducing by -51.7% on the previous year. In general, exports, however, recorded temperate growth. The pace of growth appeared the most rapid in 2021 with an increase of 856%. As a result, the exports attained the peak of 2.4 tons, and then declined notably in the following year.
In value terms, vaccine exports dropped markedly to $231K in 2022. Over the period under review, exports saw a slight shrinkage. The pace of growth appeared the most rapid in 2021 with an increase of 152%. As a result, the exports attained the peak of $325K, and then declined notably in the following year.
| Export of Vaccine in Egypt (Thousand USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Kuwait | 105 | 21.2 | 56.2 | 69.2 | -13.0% |
| Qatar | N/A | N/A | 48.8 | 56.7 | 16.2% |
| Tunisia | 0.1 | 44.8 | N/A | 42.7 | 653.0% |
| Togo | 23.8 | 7.4 | 18.5 | 21.5 | -3.3% |
| Nigeria | 38.2 | 7.2 | 10.1 | 20.7 | -18.5% |
| United Arab Emirates | 12.2 | 4.0 | 10.0 | 11.6 | -1.7% |
| Saudi Arabia | 28.0 | 1.3 | 0.1 | 8.5 | -32.8% |
| China | N/A | 34.8 | 52.5 | N/A | 50.9% |
| Somalia | N/A | N/A | 27.2 | N/A | 0% |
| Jordan | N/A | N/A | 65.1 | N/A | 0% |
| Others | 31.1 | 8.1 | 36.2 | N/A | 7.9% |
| Total | 239 | 129 | 325 | 231 | -1.1% |
Top Export Markets for Vaccine from Egypt in 2022:
- Qatar (539.0 kg)
- Saudi Arabia (196.0 kg)
- Nigeria (141.0 kg)
- Kuwait (89.0 kg)
- Togo (67.0 kg)
- United Arab Emirates (61.0 kg)
- Tunisia (47.0 kg)
This report provides an in-depth analysis of the vaccine market in Egypt. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202140 -
- Prodcom 21202145 - Vaccines for human medicine
Country coverage:
- Egypt
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Egypt
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
570
This report provides an in-depth analysis of the vaccine market in Egypt.
474
This report provides an in-depth analysis of the antisera market in Egypt.
583
This report provides an in-depth analysis of the biological product market in Egypt.
379
This report provides an in-depth analysis of the market for human and animal blood in Egypt.
760
This report provides an in-depth analysis of the veterinary medicine vaccines market in Egypt.
2856
This report provides an in-depth analysis of the global vaccine market.
2306
This report provides an in-depth analysis of the global antisera market.
565
This report provides an in-depth analysis of the global biological product market.
653
This report provides an in-depth analysis of the global market for human and animal blood.
760
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
606
Due to widespread Covid vaccination rates, the global trade in vaccines reached $42.5B, the highest level ever. Belgium topped the country rankings by the value of exports this year, followed by Germany and the U.S. Growing global demand stimulates the rapid expansion of Covid vaccine production facilities in the EU.
1233
Belgium dominates in the global trade of vaccines for human medicine. In 2014, Belgium exported X tons of vaccines for human medicine totaling $X, X% over the previous year. Its primary trading partner was France, where it supplied X% o
291
Explore the top import markets for antisera and their key statistics. Find out which countries dominate the global import market for antisera and their import values.
1181
Global trade in antisera and other blood fractions reached the highest level ever, totalling near $182B in 2020. The U.S., Germany, China, Spain, the UK and South Korea top the world’s largest antisera exporter ranking, comprising 67% of the total shipments. More than half of antisera imports are supplied to Germany, the U.S., Austria, Spain, Italy, China and Switzerland.
1084
In 2016, the antisera and other blood fractions market grew by X% to X billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries.
1274
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
1275
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
3246
From 2007 to 2015, global exports of antisera and other blood fractions showed steady growth, amounting to X million USD in 2015. There was an annual increase of +X% throughout the analyzed period.
510
Switzerland seized control of the antisera and other blood fractions market. In 2014, Switzerland exported X thousand tons of antisera and other blood fractions totaling X billion USD, X% over the previous year. Its primary trading partner was G
245
Explore the top import markets for Biological Products worldwide, including the United States, Germany, Belgium, and more. Discover key statistics and import values in this article.
